Chimeric epitope vaccine against Leptospira interrogans infection and induced specific immunity in guinea pigs
Background Leptospirosis is an important reemerging zoonosis, with more than half a million cases reported annually, and is caused by pathogenic Leptospira species. Development of a universal vaccine is one of the major strategic goals to overcome the disease burden of leptospirosis. In this study, a chimeric multi-epitope protein-based vaccine was designed and tested for its potency to induce a specific immune response and provide protection against L. interrogans infection. Results The protein, containing four repeats of six T- and B-cell combined epitopes from the leptospiral outer membrane proteins, OmpL1, LipL32 and LipL21, was expressed and purified. Western blot analysis showed that the recombinant protein (named r4R) mainly expressed in a soluble pattern, and reacted with antibodies raised in rabbit against heat-killed Leptospira and in guinea pigs against the r4R vaccine. Microscopic agglutination tests showed that r4R antisera was immunological cross-reactive with a range of Chinese standard reference strains of Leptospira belonging to different serogroups. In guinea pigs, the r4R vaccine induced a Th1-biased immune response, as reflected by the IgG2a/IgG1 ratio and cytokine production of stimulated splenocytes derived from immunized animals. Finally, r4R-immunized guinea pigs showed increased survival of lethal Leptospira challenges compared with PBS-immunized animals and tissue damage and leptospiral colonization of the kidney were reduced. Conclusions The multi-epitope chimeric r4R protein is a promising antigen for the development of a universal cross-reactive vaccine against leptospirosis..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
BMC microbiology - 16(2016), 1 vom: 14. Okt. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lin, Xu’ai [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Cross protection |
---|
Anmerkungen: |
© The Author(s). 2016 |
---|
doi: |
10.1186/s12866-016-0852-y |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR027204502 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR027204502 | ||
003 | DE-627 | ||
005 | 20230519123438.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201007s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12866-016-0852-y |2 doi | |
035 | |a (DE-627)SPR027204502 | ||
035 | |a (SPR)s12866-016-0852-y-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lin, Xu’ai |e verfasserin |4 aut | |
245 | 1 | 0 | |a Chimeric epitope vaccine against Leptospira interrogans infection and induced specific immunity in guinea pigs |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s). 2016 | ||
520 | |a Background Leptospirosis is an important reemerging zoonosis, with more than half a million cases reported annually, and is caused by pathogenic Leptospira species. Development of a universal vaccine is one of the major strategic goals to overcome the disease burden of leptospirosis. In this study, a chimeric multi-epitope protein-based vaccine was designed and tested for its potency to induce a specific immune response and provide protection against L. interrogans infection. Results The protein, containing four repeats of six T- and B-cell combined epitopes from the leptospiral outer membrane proteins, OmpL1, LipL32 and LipL21, was expressed and purified. Western blot analysis showed that the recombinant protein (named r4R) mainly expressed in a soluble pattern, and reacted with antibodies raised in rabbit against heat-killed Leptospira and in guinea pigs against the r4R vaccine. Microscopic agglutination tests showed that r4R antisera was immunological cross-reactive with a range of Chinese standard reference strains of Leptospira belonging to different serogroups. In guinea pigs, the r4R vaccine induced a Th1-biased immune response, as reflected by the IgG2a/IgG1 ratio and cytokine production of stimulated splenocytes derived from immunized animals. Finally, r4R-immunized guinea pigs showed increased survival of lethal Leptospira challenges compared with PBS-immunized animals and tissue damage and leptospiral colonization of the kidney were reduced. Conclusions The multi-epitope chimeric r4R protein is a promising antigen for the development of a universal cross-reactive vaccine against leptospirosis. | ||
650 | 4 | |a Leptospira |7 (dpeaa)DE-He213 | |
650 | 4 | |a Outer membrane protein |7 (dpeaa)DE-He213 | |
650 | 4 | |a Multi-epitope |7 (dpeaa)DE-He213 | |
650 | 4 | |a Vaccine |7 (dpeaa)DE-He213 | |
650 | 4 | |a Cross protection |7 (dpeaa)DE-He213 | |
700 | 1 | |a Xiao, Guohui |4 aut | |
700 | 1 | |a Luo, Dongjiao |4 aut | |
700 | 1 | |a Kong, Liangliang |4 aut | |
700 | 1 | |a Chen, Xu |4 aut | |
700 | 1 | |a Sun, Dexter |4 aut | |
700 | 1 | |a Yan, Jie |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMC microbiology |d London : BioMed Central, 2001 |g 16(2016), 1 vom: 14. Okt. |w (DE-627)SPR027173240 |w (DE-600)2041505-9 |x 1471-2180 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2016 |g number:1 |g day:14 |g month:10 |
856 | 4 | 0 | |u https://dx.doi.org/10.1186/s12866-016-0852-y |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 16 |j 2016 |e 1 |b 14 |c 10 |